Evidence map›Paper›PMID 32670065›Full record

ArticleFrontiers in pharmacology2020

Corrigendum: USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition

Sudong Xue, Wei Wu, Ziyan Wang, Guangxian Lu, Jiantong Sun, Xing Jin, Linjun Xie, Xiaoyu Wang, Caihong Tan, Zheng Wang and 2 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Tankyrase 2 promotes lung cancer cell malignancy.World journal of clinical oncology · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sudong XueDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Wei WuDepartment of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
Ziyan WangDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Guangxian LuDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Jiantong SunDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Xing JinDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Linjun XieDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Xiaoyu WangDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Caihong TanDepartment of Pharmacy, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Zheng WangComprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wenjuan WangDepartment of Pharmacy, The Children's Hospital of Soochow University, Suzhou, China.
Xinyuan DingDepartment of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Nanjing Medical University · CNSuzhou Municipal Hospital · CNJiangsu University · CNSoochow University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00668.].

Indexed as

epithelial-to-mesenchymal transitionmetastasisnon-small cell lung cancerubiquitin-specific protease 5 (USP5)β-catenin

Identifiers

PMID32670065
PMCPMC7326949
OpenAlexW3021718028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.